UNSPSC 51392203: Clonidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C9H9Cl2N3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MN3L5RMN02, chemically known as 2,6-dichloro-n-imidazolidin-2-ylideneaniline but generally known as clonidine, which bears US NIH Compound Identifier 2803. European Medicines Agency schedules Clonidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06730MIG.

UNSPSC 51392203 Clonidine, a Commodity code, nominally designates a single pharmaceutical product, but the recent state and local procurement activity under this code does not reflect the abstract classification. Seminole County, Florida's IFB60459723LAS solicitation, posted June 30, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually—neither of which is clonidine. The mismatch suggests either a tagging error in the county's procurement system or a broader use of this code to encompass opioid-reversal and harm-reduction pharmaceutical procurement. The work involves specification, procurement, and quarterly delivery of emergency medical and public health supplies to a designated county facility, with vendors bearing shipping and delivery costs, E-Verify compliance, drug-free workplace certification, and compliance with potential FEMA funding conditions including the Clean Air Act and Federal Water Pollution Control Act. The contract carries a two-year initial term with a one-year renewal option and a three-month probationary termination window.

The source provides only one recent opportunity, limiting geographic characterization to Seminole County's single entry. The July 26, 2023 response deadline in the solicitation record predates the June 30, 2026 posting date by three years, suggesting either archival data or a system reconciliation issue. No other state or local jurisdictions appear in the available opportunities, and no repeat buyers or additional regional activity can be confirmed from the source. The narrow data set and the apparent mismatch between the code's nominal scope and the actual procurement content signal limited recent activity under this Commodity code that aligns with clonidine specifications.